3 results
Approved WMOCompleted
During this pilot study, we intend to investigate the feasibility of a home-based patient-tailored telemedicine self-management intervention for patients with COPD and chronic heart failure over a 4-month period.
Approved WMOCompleted
To assess the local and systemic safety and tolerability of continued ABBV-951 treatment delivered as a CSCI for 24 hours daily.
Approved WMOCompleted
To assess the local and systemic safety and tolerability of ABBV-951 delivered as a CSCI for 24 hours daily for up to 52 weeks.